CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Daebong LS Company Limited Company Snapshot
Daebong LS Company Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Daebong LS Company Limited with three other companies in this sector in South Korea: Humedix Co Ltd (2018 sales of 64.83 billion Korean Won [US$54.78 million] of which 88% was Finished goods), Pharma Reaserch Products Co Ltd (64.28 billion Korean Won [US$54.32 million] of which 43% was Merchandise-ATP), and Sam-A Pharmaceutical Company (66.95 billion Korean Won [US$56.57 million] of which 52% was Finished Goods-Respiratory machine).

Sales Analysis. Daebong LS Company Limited reported sales of 71.82 billion Korean Won (US$60.69 million) for the year ending December of 2018. This represents an increase of 9.4% versus 2017, when the company's sales were 65.65 billion Korean Won. Sales of Research saw an increase that was more than double the company's growth rate: sales were up 20.5% in 2018, from 8.31 billion Korean Won to 10.02 billion Korean Won. Not all segments of Daebong LS Company Limited experienced an increase in sales in 2018: sales of Wholesale fell 24.6% to 504.24 million Korean Won. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Daebong LS Company Limited
  Stock Performance Chart for Daebong LS Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (10/11/2019): 7,150.00
(Figures in Korean Won)
1 Week 0.7%   13 Weeks -2.7%  
4 Weeks -12.3%   52 Weeks 0.8%  
 
Daebong LS Company Limited Key Data:
  Ticker: 078140 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 71,823,250,570
(Year Ending Jan 2019).
Employees: 101
  Currency: Korean Won Market Cap: 79,269,039,850
  Fiscal Yr Ends: December Shares Outstanding: 11,086,579
  Share Type: Common Closely Held Shares: 5,647,100
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.